Articles from Caixin Global, Caixin Global

Caixin Global

Articles from Caixin Global

Caixin is a media group dedicated to providing financial and business news through periodicals, online content, mobile apps, conferences, books and TV/video programs. Caixin aims to blaze a trail that helps traditional media prosper in the new media age through integrated multimedia platforms.

News from Caixin

Cross Asset Strategy

<ul><li>In Depth: 'Zero Covid' slams the brakes on China’s electric car industry</li><li>Shanghai’s Covid hospitals struggle to handle patients with other serious illnesses</li><li>Exclusive: China’s ‘Big Four’ banks to start pilot program for retirement savings products</li></ul>

In Depth: 'Zero Covid' slams the brakes on China’s electric car industryShanghai’s Covid hospitals struggle to handle patients with other serious illnessesExclusive: China’s ‘Big Four’ banks to start pilot program for retirement savings products

CX Daily: 'Zero Covid' Slams the Brakes on China’s Electric Car Industry

Global Emerging Market Equities, Propitious Research

Wium Malan, CFA

Global Emerging Market Equities

Independent, Fundamental Quantitative Research

Propitious Research

Fully independent, fundamental and quantitative equity research, focused on companies in the Telecommunication, Media, Technology, Internet and Healthcare sectors in the Global Emerging Markets. Idea generation focused on Quality stocks, trading below their intrinsic Value, with sound Corporate Governance.

Quantitative Analysis

<ul>
<li>An overview (and output) of our machine learning-driven GEM screening model, which seeks to find the best medium-term long ideas within the top100 stocks in the MSCI GEM Index.</li>
<li>The model is based on 1) a quantitative multifactor screening model, enhanced by two AI Technology-based approaches; 2) a Deep Neural Network model, and 3) a Recurrent Neural Network model.</li>
<li>Developed over nearly 4 years and implemented in its current state for nearly 2 years, the model has a solid real-world alpha-generating performance track record, discussed in detail below.</li>
</ul>


An overview (and output) of our machine learning-driven GEM screening model, which seeks to find the best medium-term long ideas within the top100 stocks in the MSCI GEM Index.
The model is based on 1) a quantitative multifactor screening model, enhanced by two AI Technology-based approaches; 2) a Deep Neural Network model, and 3) a Recurrent Neural Network model.
Developed over nearly 4 years and implemented in its current state for nearly 2 years, the model has a solid real-world alpha-generating performance track record, discussed in detail below.


Asia Pac IPO & Placement Research, China biotech, Aequitas Research

Ke Yan, CFA, FRM

Asia Pac IPO & Placement Research, China biotech

IPOs and Placements coverage across Asia Pacific

Aequitas Research

We cover all listing across the Asia Pacific along with follow-up placements. As of Dec 2020, our team had covered 539 IPOs with a hit rate of 73.5% and 685 placements with a hit rate of 66.8%.

We combine fundamental bottom-up views with our proprietary quantitative framework to provide a holistic coverage across new listings and placements. Our coverage includes pre-IPO notes before the deal is launched, follow-up analysis once the deal is live and post-listing trading analysis as well.

<ul>
<li>We analyzed the latest HK SFC report for aggregate short position as of Feb 18. </li>
<li>Top short increases and decreases were tabulated for one week and four week period. </li>
<li>We highlight short interest changes in AIA (1299 HK) and Bank of China (3988 HK).</li>
</ul>


We analyzed the latest HK SFC report for aggregate short position as of Feb 18. 
Top short increases and decreases were tabulated for one week and four week period. 
We highlight short interest changes in AIA (1299 HK) and Bank of China (3988 HK).


<ul>
<li>We analyzed the latest HK SFC report for aggregate short position as of Feb 11. </li>
<li>Top short increases and decreases were tabulated for one week and four week period. </li>
<li>We highlight short interest changes in Bank of China, Wuxi Biologics, and Wuxi Apptec.</li>
</ul>


We analyzed the latest HK SFC report for aggregate short position as of Feb 11. 
Top short increases and decreases were tabulated for one week and four week period. 
We highlight short interest changes in Bank of China, Wuxi Biologics, and Wuxi Apptec.


HK Short Interest: BOC, Wuxi Biologics/Apptec

China

Bank of China Limited provides banking services. The Company offers deposits, loans, foreign currency transaction, fund settlement, and other services. Bank of China provides its services to individuals, enterprises, and other clients.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Bank of China (601988 CH)

CX Daily: 'Zero Covid' Slams the Brakes on China’s Electric Car Industry

In Depth: 'Zero Covid' slams the brakes on China’s electric car industry. Shanghai’s Covid hospitals struggle to handle patients with other serious...

Caixin Global

Screening for GEMs: March 2022

This insight provides an overview of our, machine learning-driven, proprietary GEM screening model, based on a Multifactor model, a Deep Neural...

Wium Malan, CFA

HK Short Interest: AIA, Bank of China

We highlight week on week short interest changes in AIA (1299 HK) and Bank of China (3988 HK) based on the latest HK SFC short aggregate report.

Ke Yan, CFA, FRM

HK Short Interest: BOC, Wuxi Biologics/Apptec

We highlight week on week short interest changes in Bank of China, Wuxi Biologics, and Wuxi Apptec based on the latest Hong Kong SFC short...

Ke Yan, CFA, FRM

Screening for GEMs: February 2022

This insight provides an overview of our, machine learning-driven, proprietary GEM screening model, based on a Multifactor model, a Deep Neural...

Wium Malan, CFA

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)